COVID-19 researchers are expected to begin using artificial intelligence (AI) and machine learning to data-mine new clues and insights regarding COVID-19. The Office of Science and Technology Policy issued a call to action for researchers to start using this technology to sort through the scholarly data on the topic using a newly created database.
Major healthcare organizations would like a better understanding of how COVID-19 originated and how it spreads to better develop a potential treatment. AI could help in this regard, as this technology is capable of scanning the 29,000 or so scholarly articles on the subject much faster than a human can. This could lead to the discovery of new clues and insights that otherwise would be near impossible for a person to find.
Image source: Getty Images.
U.S. Chief Technology Officer Michael Kratsios told reporters in a conference call that using AI and machine learning could greatly aid research efforts, calling this database the "most extensive collection of machine readable coronavirus literature to date." However, the database is far from complete. Only 13,000 of the 29,000 articles have been fully uploaded onto the database at the moment. The remaining 16,000 articles have had their abstracts uploaded, but little else.
Working with the private sector
The White House said that it partnered with a number of private-sector tech giants, including Google and Microsoft, to help compile an extensive database of articles regarding COVID-19. Other organizations include the National Library of Medicine, the Allen Institute of AI, as well as the Chan Zuckerberg Initiative, named after the wife of Facebook's CEO, Mark Zuckerberg.
10 stocks we like better than Microsoft
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Microsoft wasn't one of them! That's right -- they think these 10 stocks are even better buys.
*Stock Advisor returns as of December 1, 2019
Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. Mark Prvulovic has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Facebook and Microsoft and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
